Gayathri Kallukaran is a Junior Journalist with Eastern Eye. She has a Master’s degree in Journalism and Mass Communication from St. Paul’s College, Bengaluru, and brings over five years of experience in content creation, including two years in digital journalism. She covers stories across culture, lifestyle, travel, health, and technology, with a creative yet fact-driven approach to reporting. Known for her sensitivity towards human interest narratives, Gayathri’s storytelling often aims to inform, inspire, and empower. Her journey began as a layout designer and reporter for her college’s daily newsletter, where she also contributed short films and editorial features. Since then, she has worked with platforms like FWD Media, Pepper Content, and Petrons.com, where several of her interviews and features have gained spotlight recognition. Fluent in English, Malayalam, Tamil, and Hindi, she writes in English and Malayalam, continuing to explore inclusive, people-focused storytelling in the digital space.
Bryan Johnson, a 47-year-old tech entrepreneur from California, has become a prominent figure in the global longevity movement, attracting both fascination and criticism for his intense health regime. Known for creating the “Don’t Die” project, Johnson has turned his body into a human laboratory, experimenting with extreme methods to delay ageing and boost long-term health.
From tech success to health obsession
Johnson made headlines in 2013 after selling his company, Braintree, to PayPal for $800 million. Following years of depression and personal upheaval, including leaving the Church of Jesus Christ of Latter-day Saints and divorcing his wife, Johnson redirected his focus to health and longevity.
Now, he claims to live with a singular goal: to be the healthiest and most biologically youthful person alive. He documents his journey on social media, where he has 1.8 million Instagram followers, and recently appeared in the Netflix documentary Don’t Die: The Man Who Wants to Live Forever.
A day in the life of Bryan Johnson
Johnson’s daily routine is strict and meticulously planned. He wakes at 4:30am and begins his day with light therapy to regulate his circadian rhythm, followed by exercise, sauna sessions, and hyperbaric oxygen therapy. He wears a red-light cap for hair growth and consumes a carefully measured breakfast.
He takes around 40 supplements each day, including vitamin D, magnesium, creatine and collagen peptides. His calorie intake is limited to 2,250 per day, with a focus on plant-based ingredients and healthy fats such as olive oil, which he includes in his shakes and meals. His final meal is consumed at least four hours before bedtime.
His bedtime is 8:30pm, following a wind-down routine involving reading, journaling and family time. He avoids evening exercise and limits screen time in the evening to promote better sleep.
Tracking health by the numbers
Johnson tracks an extraordinary range of metrics. He takes over 33,000 internal images daily via colonoscopy, monitors his heart rate and organ performance, and even uses the presence of night-time erections as a marker of biological health. He believes these physiological signs indicate whether the body is functioning at an optimal level.
His health data includes:
Heart health comparable to a 37-year-old
Skin age estimated at 28
Lung capacity of an 18-year-old
Body fat consistently between 5 and 6 per cent
One hour of daily exercise plus several high-intensity sessions weekly
Longevity as a lifestyle
For Johnson, rejuvenation is not a hobby but a competitive pursuit. “Rejuvenation is my sport,” he explains. “I feel energetic, clear-headed and my mood is stable. That’s my reward. It’s just a really great way to navigate life.”
He argues that most people begin by criticising his lifestyle but often reconsider once they see results. “People are initially critical, then they want to feel good too – and then they change their habits.”
Despite his regimented lifestyle, Johnson makes space for community. He hosts early morning dance parties and evening gatherings to maintain social connections, which he views as essential for health and longevity. He describes socialising as “one of the most important things anyone can do.”
Parenting and personal life
Johnson shares his health principles with his teenage son, Talmage, and the pair enjoy outdoor sports such as hiking, biking and running. He has previously undergone plasma transfusions involving his son, although he has since moved on to other treatments.
He discontinued taking rapamycin after research suggested it could accelerate ageingNetflix
His approach to relationships and dating is less straightforward. He admits that his tightly structured life can make romantic partnerships difficult due to scheduling demands.
Treatments he’s abandoned
Johnson is open about treatments that have not worked. He discontinued taking rapamycin after research suggested it could accelerate ageing, despite initial promise in anti-ageing studies.
He also avoids environmental pollutants by minimising plastic use in his home and kitchen, testing water monthly for contaminants, and even manufacturing some of his own food to control for heavy metals.
A controversial but influential figure
While his methods may appear extreme, Johnson says he is motivated by a desire to avoid the health decline he experienced during his depression. “The greatest joy in my day is that I don’t feel depressed,” he says. “Even though I take so much heat in the world… I feel great, I’m having fun and I enjoy life.”
Rather than aiming to live forever, he says his focus is simply not wanting to die now. “We all want to wake up tomorrow and feel great, for our body to move, and to have no aches and pains. It’s about being your best, moment to moment.”
Novo Nordisk loses $70bn (£52bn) in market value after major share price slump
Company cuts annual forecasts for both profit and revenue
Faces mounting competition from Eli Lilly’s Mounjaro and unauthorised compound drugs
Executive reshuffle announced as Maziar Mike Doustdar takes over as CEO
UK access to weight-loss jabs remains tightly restricted under NHS guidelines
Novo Nordisk hit by sharp fall as rivals gain ground
Novo Nordisk’s shares fell by more than 20% on Tuesday—its steepest one-day drop—wiping $70bn (£52bn) off its market capitalisation. The crash follows a revised outlook by the company, which lowered its full-year profit and sales expectations amid growing competitive pressure in the obesity drug market.
The fall pushes Novo Nordisk behind European luxury brands LVMH and Hermès in the rankings of the continent’s biggest listed companies, just weeks after reclaiming the top spot.
Profit warning and weaker sales forecast
The Danish drugmaker revised its 2025 guidance, with sales now expected to grow between 8% and 14%, down from 13% to 21%. Projected profit growth was similarly trimmed to 10%–16%, compared to the earlier range of 16%–24%.
The downgrade is attributed to several factors, including increasing demand for cheaper compound drugs—unlicensed versions of Novo’s injections—as well as competition from Eli Lilly’s GLP-1 rival, Mounjaro (Zepbound in the US).
Leadership shake-up at a critical time
Novo Nordisk announced that Maziar Mike Doustdar, currently leading international operations, will assume the role of chief executive. He will be tasked with reviving flagging demand, especially in the crucial US market.
Doustdar pledged to “increase the sense of urgency and execute differently”, aiming to “turn the picture around” in the US where market share is slipping.
Mounjaro closes in on GLP-1 dominance
GLP-1 drugs, designed to mimic hormones that regulate appetite and satiety, have become central to the growing global demand for weight-loss treatments. A recent head-to-head clinical trial, funded by Eli Lilly, showed Mounjaro delivering 20% average weight loss over 72 weeks—outperforming Novo’s Wegovy, which delivered a 14% reduction.
In May, Eli Lilly surpassed Novo Nordisk in its share of the US GLP-1 market for the first time.
Legal battles and regulatory hurdles
Novo continues to challenge unauthorised versions of its obesity jabs in court. Despite intervention by the US FDA to limit the proliferation of these compound drugs, Novo claims that mass production persists under claims of customisation and personalisation.
The company says these imitations not only pose regulatory risks but also endanger patient safety.
Limited NHS access in the UK
In the UK, Eli Lilly has gained an advantage with approval for Mounjaro to be prescribed through GP surgeries. In contrast, Novo Nordisk’s Wegovy is only available via specialist NHS weight management services.
Strict eligibility applies: patients must have a BMI over 40 and at least four related health conditions such as type 2 diabetes or sleep apnoea to qualify.
Novo’s UK chief, Sebnem Avsar Tuna, recently called on the government to broaden access, suggesting the UK could “be a role model” in tackling obesity through innovation.
Health Secretary Wes Streeting has echoed support for wider use, stating that access should be “based on need and not the ability to pay”. The government is now piloting accelerated schemes for rollout of such treatments.
By clicking the 'Subscribe’, you agree to receive our newsletter, marketing communications and industry
partners/sponsors sharing promotional product information via email and print communication from Garavi Gujarat
Publications Ltd and subsidiaries. You have the right to withdraw your consent at any time by clicking the
unsubscribe link in our emails. We will use your email address to personalize our communications and send you
relevant offers. Your data will be stored up to 30 days after unsubscribing.
Contact us at data@amg.biz to see how we manage and store your data.
Making healthy choices has become increasingly difficult in the modern world
NHS surgeon Dr Karan Rajan promotes a simple three-ingredient recipe to support gut health and muscle maintenance.
The snack includes kefir yoghurt, raspberries, and chia seeds — all rich in fibre, protein, and beneficial compounds.
Dr Rajan advocates for low-cost, preventative health strategies over expensive treatments.
He stresses that fibre is often overlooked despite playing a crucial role in overall health.
His TikTok channel and book aim to make scientific health advice accessible to the public.
Simple advice, powerful results
Making healthy choices has become increasingly difficult in the modern world. From ultra-processed supermarket food to endless distractions on our devices, temptation is often just a click away. But NHS surgeon Dr Karan Rajan is working to make health advice more accessible, affordable and actionable — and his approach is finding a wide audience.
Dr Rajan, who has built a following of more than five million on TikTok, uses short-form videos to break down complex medical science into practical tips. His new book, This Book May Save Your Life, compiles what he describes as “everyday health hacks to worry less and live better”.
He believes the popularity of his content reflects a wider shift in public health thinking. “Healthcare systems in most countries have flaws,” Dr Rajan told The Independent. “It’s harder to see a healthcare professional in some cases, particularly for chronic diseases. It’s also expensive if you are going down the private route. People are realising that prevention is a cheaper, more effective longer-term solution for health than treatment when burdened with disease.”
Gut health on a budget
One of Dr Rajan’s most popular tips is a simple three-ingredient snack that supports both gut health and muscle strength. It’s cost-effective, easy to prepare, and packed with nutritional value.
To make the snack, start by microwaving the raspberries for around 30 seconds, then mash them to your desired consistency. The deep red colour signals the presence of anthocyanins — antioxidants linked to gut health. This serving alone offers roughly 5g of fibre.
Next, stir in a tablespoon of chia seeds. These are rich in both fibre and mucilage — a type of soluble fibre that feeds beneficial bacteria in the colon. The chia seeds also help thicken the mixture into a jam-like texture.
Finally, use the mixture as a topping on kefir yoghurt — a fermented dairy product that contains live cultures and offers an additional boost of probiotics and protein. An optional drizzle of honey can be added for sweetness.
Dr Rajan calls this a “power combo” — containing the three Ps of gut health: prebiotics, probiotics, and polyphenols.
Why fibre matters more than you think
While protein remains a hot topic in fitness and nutrition, Dr Rajan says fibre is the real unsung hero of good health.
“Both protein and fibre are essential,” he says. “There are plenty of foods and meal combos where you can get both, but if I had to over-index on one, it would be fibre.”
According to Dr Rajan, most adults in the UK don’t come close to the recommended 30g of dietary fibre per day, with average intakes falling below 20g. This gap, he warns, is causing many to miss out on wide-ranging health benefits.
“When it comes to human physiology, there aren’t many processes in] fibre isn’t involved in, either directly or indirectly,” he says. “Its benefits include regulating hormones, metabolism, appetite, the gut microbiome, mood, bowels and more.”
Prevention over cure
The popularity of Dr Rajan’s content may lie in its simplicity and evidence-based approach. Rather than focusing on quick fixes or restrictive diets, he promotes everyday changes that can be sustained long-term. His three-ingredient snack is a clear example of that philosophy — easy to make, nutritionally rich, and based on solid science.
As access to healthcare becomes more challenging for many, he believes prevention is not just practical but necessary.
“People want advice they can trust, but also apply,” he says. “Improving gut health and increasing fibre intake are two changes most people can make today — and they’ll feel better for it.”
Keep ReadingShow less
Samaritans currently has 22,000 listening volunteers
Samaritans plans to close at least half of its 200 branches over the next 7–10 years
Volunteers to be moved into larger regional hubs and remote call handling to be piloted
Charity says model is unsustainable; changes aim to increase volunteer flexibility and service capacity
Some volunteers express concern over the loss of smaller branch camaraderie and safe spaces
Final decision expected in September following consultation
Mental health charity plans shift to larger hubs and remote volunteering
Samaritans has announced plans to close at least 100 of its 201 branches across the UK and Ireland in the next seven to ten years, as part of a major restructuring strategy aimed at improving service delivery and reducing infrastructure costs.
The charity, which operates a 24/7 mental health helpline, says it intends to move volunteers into larger regional centres and trial a remote volunteering model. The shift is intended to provide greater flexibility, increase the number of volunteers on shift at any time, and reduce spending on building maintenance.
Concerns raised over impact on volunteers
Samaritans currently has 22,000 listening volunteers who answer calls and messages from people experiencing mental health crises. The helpline receives a call every 10 seconds, and many branches also offer in-person support.
In a video shared with volunteers, Chief Executive Julie Bentley said the charity’s limited fundraising income was increasingly being used to maintain physical branches, instead of improving services.
“Over 200 branches, varying in size from 10 to 300 volunteers, is not sustainable and hinders us providing the best possible service to people who need us,” she said. “We are engaging with our volunteers on proposed improvements that will mean we are able to answer more calls, have more volunteers on duty, and be there for more people in their darkest moments.”
The charity emphasised that it does not intend to reduce the level of service it offers. Instead, it hopes to expand its reach by making buildings and shifts more accessible and increasing volunteer numbers through flexible models.
Volunteer response: fears of “call centre-style” culture
Despite the stated goals, some long-standing volunteers have raised concerns that the changes could lead to a loss of the close-knit environment offered by smaller branches. There is particular unease about the possible shift to a “call centre-style” approach, which some feel could compromise the sense of community and safety among volunteers.
One volunteer commented:
“The current system has operated very successfully for 70 years. Now they’re thinking of dismantling it. Almost every volunteer I’ve spoken to has said if they introduce call centres, we’re out.”
Others voiced discomfort at the idea of taking sensitive calls from home, even with video support from fellow volunteers, citing the importance of having a safe, supportive physical environment.
Financial pressures and long-term planning
The proposed changes come amid financial challenges for the organisation. In its 2023–24 accounts, Samaritans reported declining income for the third consecutive year and rising operational costs.
The charity’s accounts show:
£7 million allocated to fixed assets, including branches
A property maintenance fund of £28,000
A branch support fund of £287,000
£24.6 million in charitable income
Volunteers have requested more transparency around projected cost savings from branch closures and how these funds will be reinvested.
Consultation ongoing ahead of decision
Samaritans has said that no final decisions will be made until after a consultation period concludes in September. If approved, the changes will be introduced gradually over a number of years.
The charity maintains that modernising the structure is essential for long-term sustainability and to meet the evolving needs of callers and volunteers alike.
Keep ReadingShow less
Social media has recently drawn attention to the psychological challenges
Mounjaro (tirzepatide) is a diabetes drug also prescribed for weight loss
Users report emotional side effects, including low motivation and feeling “stuck”
A TikTok post describing the “slow middle” of weight loss struck a chord with others
The injection can support weight loss of up to 20% over a year
Drug is now sold in UK supermarkets including Tesco and Morrisons
While Mounjaro has become increasingly popular for aiding weight loss, users have begun highlighting a less-discussed side effect — an emotional downturn midway through treatment.
The medication, also known by its generic name tirzepatide, is a weekly injection originally developed to manage type 2 diabetes. It has since gained traction for its weight loss benefits, with some patients shedding up to 20% of their body weight over the course of a year.
Now available in UK supermarket pharmacies, including Tesco and Morrisons, Mounjaro is being used more widely — but not all side effects are physical.
TikTok user describes the “slow middle” struggle
Social media has recently drawn attention to the psychological challenges that can emerge partway through treatment. TikTok creator @Swedish_Sandra described feeling emotionally flat and demotivated despite ongoing physical progress.
“It’s the period of time between the before and after photos,” she explained in a recent post. “This phase feels quiet — not the start, not the finish, just the slow middle where everything is shifting but the big change isn’t visible yet.”
Sandra encouraged others to recognise that this emotional plateau is part of the journey, calling it “the hardest bit mentally” and stressing the importance of patience and perseverance.
Users share similar experiences
Sandra’s experience resonated with many who commented on her post, saying they too had noticed a dip in motivation once the initial rapid weight loss slowed.
“I’ve been struggling for the last month wondering if all this money is worth it,” wrote one user. “My weight loss has stalled too,” added another. “It is hard to get used to when you’re used to big drops at the start.”
Several commenters offered support and perspective, with one noting:
“Even a quarter of a pound a week is still a loss. This is the phase where the weight lost is likely fat, not just water. That’s real progress.”
Sandra responded:
“The initial excitement has died down, but those ‘boring’ moments are where the steady, lasting change happens.”
A reminder that weight loss is not linear
While Mounjaro has proven effective for weight loss, the emotional and mental health aspects of the process are increasingly part of the conversation. Users are calling for greater openness around the slower, less visible phases of the journey.
The drug remains a significant tool for people managing obesity or type 2 diabetes, but the growing number of personal accounts highlight the importance of setting realistic expectations and maintaining emotional resilience throughout treatment.
Keep ReadingShow less
Many of those targeted missed their vaccine during school years
NHS encourages unvaccinated people aged 16–25 to get the HPV vaccine
Over 418,000 school leavers in past three years missed vaccination
HPV vaccine protects against cervical and other related cancers
NHS aiming for 90% uptake among girls by 2040
Letters, emails, texts and NHS App alerts being used for reminders
NHS campaign targets unvaccinated young adults
The NHS is urging hundreds of thousands of young people aged 16 to 25 to come forward for the HPV vaccine, which protects against cervical and other types of cancer.
Many of those targeted missed their vaccine during school years. According to NHS England, over 418,000 children left school without receiving the HPV jab in the past three years.
As part of a national campaign to increase uptake, GP practices are contacting eligible patients using letters, text messages, emails and the NHS App.
Addressing regional disparities and missed vaccinations
The vaccine is routinely offered to boys and girls aged 12 to 13. However, government data from June 2024 highlighted regional inequalities in vaccine uptake. The lowest rates were reported in London, across both male and female Year 10 pupils during the 2023–2024 school year.
The UK Health Security Agency (UKHSA) and NHS England are now focusing on improving awareness and access for young adults who missed vaccination earlier in life.
HPV vaccine effectiveness and long-term plans
The NHS aims to eliminate cervical cancer by 2040 under its 10-Year Health Plan, which includes boosting vaccine uptake to 90% among girls and increasing participation in cervical screening.
The vaccine also helps prevent cancers of the mouth, throat, anus, penis and vagina caused by the human papillomavirus (HPV).
Introduced in 2021, the latest version of the HPV vaccine is more effective than the previous type. Long-term projections suggest it could reduce cases of women's cancer by 16% and HPV-related deaths by 9%.
Research in England shows that the vaccine prevents 90% of cervical cancer cases.
Catch-up vaccinations available for adults
Catch-up doses are available to:
Anyone up to age 25 who missed their school vaccination
Adults up to age 45 with immune-compromised conditions
Men who have sex with men
Dr Amanda Doyle, National Director for Primary Care and Community Services at NHS England, said: “Too many lives are lost to cervical cancer. The hard work of NHS staff in vaccinating and screening as many people as possible will help us meet our ambition of wiping out this disease.”
Dr Sharif Ismail, Director of Public Health Analysis at UKHSA, added: “Uptake of the HPV vaccination has dropped significantly since the pandemic, leaving thousands at greater risk. We urge all parents to return consent forms promptly, and young adults should speak to their GP about catch-up options. It’s never too late to get protected.”